Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-236-9 | CAS number: 79-94-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- two-generation reproductive toxicity
- Remarks:
- based on test type (migrated information)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 8th January 2001 - 11th December 2002
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study, conducted according to standardized guidelines, with analytical verification of test compound concentrations
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 002
- Report date:
- 2003
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 008
- Report date:
- 2008
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 416 (Two-Generation Reproduction Toxicity Study)
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
Test material
- Details on test material:
- - Name of test material (as cited in study report): Tetrabromobisphenol-A
- Molecular formula (if other than submission substance): N/A
- Molecular weight (if other than submission substance): N/A
- Smiles notation (if other than submission substance): N/A
- InChl (if other than submission substance): N/A
- Structural formula attached as image file (if other than submission substance): see Fig. N/A
- Substance type: Monoconstituent
- Physical state: Solid, white powder
- Analytical purity: 98.91%
- Impurities (identity and concentrations):
Tetrabromobisphenol-A: 98.91%
o,p- Tetrabromobisphenol-A: 0.05%
2,4,6-Tribromophenol: <0.01%
Tribromobisphenol-A: 1.04%
- Composition of test material, percentage of components: See above
- Isomers composition: See above
- Purity test date: 4 and 5 January 2001
- Lot/batch No.: Composite of 5381B, and 5381
- Expiration date of the lot/batch: Not reported
- Radiochemical purity (if radiolabelling):
- Specific activity (if radiolabelling):
- Locations of the label (if radiolabelling):
- Expiration date of radiochemical substance (if radiolabelling):
- Stability under test conditions: Not reported
- Storage condition of test material: Room temperature, Desiccated, Dry well-ventilated area
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Portage MI USA
- Age at study initiation: (P) 6 wks; (F1)3 wks
- Weight at study initiation: (P) Males: 258 to 338 g; Females: 190 to 248 g; (F1) 327.7 to g
- Fasting period before study: Not reported
- Housing: Individually in hanging wire mesh cages
- Diet (e.g. ad libitum): Lab Diet #5002, ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 12 weeks
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 14 to 25C
- Humidity (%): 30 to 70%
- Air changes (per hr): Not reported
- Photoperiod (hrs dark / hrs light): 12 hr light: 12hr dark
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: measured weight of TBBPA was mixed into known amount of vehicle
DIET PREPARATION
- Rate of preparation of diet (frequency): Weekly
- Mixing appropriate amounts with (Type of food): corn oil for gavage
- Storage temperature of food: Refrigerated
VEHICLE
- Justification for use and choice of vehicle (if other than water): None, given (standard vehicle for gavage exposures)
- Concentration in vehicle: Not reported
- Amount of vehicle (if gavage): 5mL/kg/day
- Lot/batch no. (if required): 1940.01
- Purity: Not reported - Details on mating procedure:
- - M/F ratio per cage: 1:1
- Length of cohabitation: Maximum 14 days
- Proof of pregnancy: vaginal plug / sperm in vaginal smear
- Further matings after two unsuccessful attempts: None after the 14 day period
- After successful mating each pregnant female was caged (how): individually
- Any other deviations from standard protocol: None reported - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- At the 2.0 mg/mL concentration level (10 mg/kg/day) the mean analytical value for the 12 weeks of analysis was 2.05 mg/mL or 103% of nominal.
At the 20 mg/mL concentration level (100 mg/kg/day), the mean analytical value for the 12 weeks of analysis was 19.8 mg/mL or 99% of nominal.
At the 200 mg/mL concentration level (1000 mg/kg/day), the mean analytical value for the 12 weeks of analysis was 212 mg/mL or 106% of nominal. - Duration of treatment / exposure:
- 36 weeks
- Frequency of treatment:
- Daily
- Details on study schedule:
- - Selection of parents from F1 generation when pups were 35 days of age.
- Age at mating of the mated animals in the study:14 weeks
Doses / concentrations
- Remarks:
- Doses / Concentrations:
10, 100, 100 mg/kg/day
Basis:
actual ingested
- No. of animals per sex per dose:
- 30 male and 30 female
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: Results of previous studies
- Rationale for animal assignment (if not random): Random - Positive control:
- N/A
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: Twice per day, seven days per week
- Cage side observations included: morbidity, mortality, and signs of injury.
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: Once per week
BODY WEIGHT: Yes
- Time schedule for examinations: Weekly
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: No
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: No data - Oestrous cyclicity (parental animals):
- Vaginal smears (lavage) were performed daily beginning three weeks prior to pairing in all parental females (P and FJ to establish estrous cyclicity.
- Sperm parameters (parental animals):
- Parameters examined in all male parental generations: Daily sperm production, sperm motility, epididymal sperm count and morphology
- Litter observations:
- STANDARDISATION OF LITTERS
- Performed on day 4 postpartum: Yes
- If yes, maximum of 8 pups/litter ; excess pups were killed and discarded.
PARAMETERS EXAMINED
The following parameters were examined in all offspring: number and sex of pups, stillbirths, live births, presence of gross anomalies, weight gain, physical or behavioural abnormalities
GROSS EXAMINATION OF DEAD PUPS: Yes - Postmortem examinations (parental animals):
- SACRIFICE
- Male animals: All surviving animals until completion of parturition
- Maternal animals: All surviving animals after the last litter of each generation was weaned
GROSS NECROPSY- Gross necropsy consisted of external and internal examinations including the cervical, thoracic, and abdominal viscera
HISTOPATHOLOGY / ORGAN WEIGHTS
See table 1. - Postmortem examinations (offspring):
- SACRIFICE
- The F1 offspring not selected as parental animals and all F2 offspring were sacrificed at weaning
- These animals were subjected to postmortem examinations as follows: gross pathology, histopathology organ weights
GROSS NECROPSY
- Gross necropsy consisted of external and internal examinations including the cervical, thoracic, and abdominal viscera
HISTOPATHOLOGY / ORGAN WEIGHTS
The tissues indicated in Table 1 were prepared for microscopic examination and weighed - Statistics:
- Group pair-wise comparisons, Fisher's extact test, Arcsin-Square-Root transformation
- Reproductive indices:
- Litter size, live pups, pup sex ratio, stillborn, mean pup weight
- Offspring viability indices:
- Not reported
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Other effects:
- not specified
- Description (incidence and severity):
- Test substance intake: Assumed complete, as exposed via gavage
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- no effects observed
- Reproductive function: sperm measures:
- no effects observed
- Reproductive performance:
- no effects observed
Details on results (P0)
F1 generation male rats given 100 or 1000 mg/kg/day. Mild inconsistent alterations in T3 values were noted for some female rats that were considered of equivocal relationship to TBBP A.
Effect levels (P0)
open allclose all
- Dose descriptor:
- NOEL
- Remarks:
- thyroid hormone levels
- Effect level:
- 10 mg/kg bw/day
- Sex:
- male
- Basis for effect level:
- other: NOEL for effects of TBBPA on thyroid hormone levels was 10 mg/kg/day based on lower T3 and T4 levels at the 100 and 1000 mg/kg/day dose levels
- Remarks on result:
- other: Generation: P and F1 parental (migrated information)
- Dose descriptor:
- NOEL
- Remarks:
- reproductive performance and pup toxicity
- Effect level:
- 1 000 mg/kg bw/day
- Sex:
- male/female
- Basis for effect level:
- other: The NOEL for reproductive performance and pup toxicity was 1000 mg/kg/day, the highest dose level evaluated.
- Remarks on result:
- other: Generation: all generations tested (migrated information)
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Sexual maturation:
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Histopathological findings:
- no effects observed
Details on results (F1)
Effect levels (F1)
- Dose descriptor:
- NOEL
- Remarks:
- parental toxicity
- Generation:
- F1
- Effect level:
- 100 mg/kg bw/day
- Sex:
- male
- Basis for effect level:
- other: Lower body weights and body weight gain in males at the 1000 mg/kg/day dose level
Results: F2 generation
Effect levels (F2)
- Dose descriptor:
- NOEL
- Remarks:
- developmental neurotoxicity/neuropathology
- Generation:
- F2
- Effect level:
- 100 mg/kg bw/day
- Sex:
- male/female
- Basis for effect level:
- other: In the DNT/NP component, the NOEL was 100 mg/kg/day based on subtle morphometric changes in the parietal cortex in the brains of the Day 11 F2 pups in the 1000 mg/kg/day group.
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Any other information on results incl. tables
Table 1: Summary of P Male Mean Thyroid Hormone Values
Endpoint |
0 mg/kg/day |
10 mg/kg/day |
100 mg/kg/day |
1000 mg/kg/day |
TSH ng/mL |
15.10 |
11.47 |
14.4 |
14.93 |
T4 ng/dL |
4.70 |
5.08 |
3.9* |
3.38* |
T3 ng/dL |
102.7 |
92.8 |
97.5 |
83.2* |
* significantly different from controls p<0.05
Table 2: Summary of P Female Mean Thyroid Hormone Values
Endpoint |
0 mg/kg/day |
10 mg/kg/day |
100 mg/kg/day |
1000 mg/kg/day |
TSH ng/mL |
10.80 |
9.77 |
10.32 |
9.70 |
T4 ng/dL |
4.23 |
3.45 |
3.5 |
2.39* |
T3 ng/dL |
94.8 |
96.0 |
87.5 |
90.8 |
* significantly differrent from controls p<0.05
Table 3: Summary of F1 Male Mean Thyroid Hormone Values
Endpoint |
0 mg/kg/day |
10 mg/kg/day |
100 mg/kg/day |
1000 mg/kg/day |
TSH ng/mL |
11.92 |
10.67 |
13.34 |
9.12 |
T4 ng/dL |
6.29 |
5.98 |
3.91* |
3.33* |
T3 ng/dL |
116.8 |
112.6 |
105.9 |
108.2 |
* significantly different from controls, p<0.05
Table 4: Summary of F1 Female Mean Thyroid Hormon Values
Endpoint |
0 mg/kg/day |
10 mg/kg/day |
100 mg/kg/day |
1000 mg/kg/day |
TSH ng/mL |
10.23 |
8.90 |
11.74 |
7.40 |
T4 ng/dL |
6.00 |
4.42 |
3.40* |
3.41* |
T3 ng/dL |
112.7 |
102.2 |
101.3 |
140.7 |
* significantly different from controls, p<0.05
Applicant's summary and conclusion
- Conclusions:
- In this 2-generation reproduction study with TBBPA the No Observed Effect Level (NOEL) for parental toxicity was 100 mg/kg/day based on lower body weights and body weight gain in males at the 1000 mg/kg/day dose level. The NOEL for effects of TBBPA on thyroid hormone levels was 10 mg/kg/ day based on lower T3 and T 4 levels at the 100 and 1000 mg/kg/day dose levels. TSH levels, however, were not affected at any of the dose levels in either generation. The NOEL for reproductive performance and pup toxicity was 1000 mg/kg/day, the highest dose level evaluated. In the DNT/NP component, the NOEL was 100 mg/kg/day based on subtle morphometric changes in the parietal cortex in the brains of the Day 11 F2 pups in the 1000 mg/kg/day group.
- Executive summary:
The objective of this reproduction study was to provide general information concerning the effects of Tetrabromobisphenol A (TBBPA) over the course of two generations (P and F1) and the growth and development of the offspring (F1 and F2). The study
consisted of three treatment groups (10, 100 and 1000 mg/kg/day) and a vehicle (corn oil)- treated control group (30 CD Sprague-Dawley rats/sex/group/generation). TBBPA was administered orally via gastric intubation. Animals were treated seven days a week throughout the study. Dosing suspensions were prepared fresh weekly. For breeding of the P and F1 generations, one male was paired with one female from the same treatment group continuously until mating occurred or for 14 consecutive days. At weaning of each F1 litter, at least one pup/sex/litter was selected to continue on study as the F1 parental generation (30 pups/sex/group). These pups started treatment on PND 22.
Detailed clinical examinations, body weights, and food consumption were recorded periodically throughout the study for the P and F1 parental animals. All pups were monitored for appearance, growth, and survival throughout the lactation period
Several days before terminal euthanasia of the P and F1 animals, blood was collected from 10 randomly selected animals/sex/group and analyzed for thyroid hormone levels (TSH, T3 and T4) At necropsy, P and F1 animals received a macroscopic examination and reproductive tissues and other designated tissues were taken, weighed, and preserved. Reproductive tissues were evaluated microscopically for all P and F1 animals in the control and 1000 mg/kg/day groups. Gross lesions were also examined microscopically for all parental animals. Sperm evaluations (motility, caudal epididymal sperm counts, homogenization-resistant testicular sperm head counts, and morphology) for P and F1 males and a count of primordial follicles were conducted for P and F1 females. At weaning, the unselected F1 pups and one F1 pup/sex/litter were euthanized, necropsied, specific organs weighed (brain, spleen, and thymus), and gross lesions preserved.
Dosing formulations were homogeneous at the batch size prepared and stable when refrgerated to 14 days. Mean recoveries from the periodic analyses of dosing suspensions used on study were 101 %, 99%, and 105% of nominal for the 10, 100, and 1000 mg/kg/day groups, respectively.
No effect of treatment was seen for mortality in the P and F1 generations. The low incidence of mortality seen in these animals was considered incidental and unrelated to treatment with TBBPA.
In the parental generations, the only effect of treatment with TBBPA was seen in the F1 males at 1000 mg/kg/day and involved lower body weights for several weekly intervals during the study and lower weight gain over the entire Week 1-11 premating period. At 100 and 1000 mg/kg/day, some treatment-related effects on some thyroid hormone parameters (T3 and T4) were seen. No effect of treatment in either generation was evident from other endpoints. No effect on body weights or body weight gain was seen in the P animals or F1 parental females. Likewise, no adverse effect on food consumption was seen in the treated groups for either generation.
Thus, in this 2-generation reproduction study with TBBPA the No Observed Effect Level (NOEL) for parental toxicity was 100 mg/kg/day based on lower body weights and body weight gain in males at the 1000 mg/kg/day dose level. The NOEL for effects of TBBPA on thyroid hormone levels was 10 mg/kg/ day based on lower T3 and T4 levels at the 100 and 1000 mg/kg/day dose levels. TSH levels, however, were not affected at any of the dose levels in either generation. The NOEL for reproductive performance and pup toxicity was 1000 mg/kg/day, the highest dose level evaluated. In the DNT/NP component, the NOEL was 100 mg/kg/day based on subtle morphometric changes in the parietal cortex in the brains of the Day 11 F2 pups in the 1000 mg/kg/day group.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
This website uses cookies to ensure you get the best experience on our websites.
Find out more on how we use cookies.